Since 1989 Marina Emborg has been working in pre-clinical models of neurodegenerative disorders and the development of novel therapeutic strategies.
She obtained her MD and later her PhD at the University of Buenos Aires, where her doctoral thesis was in models of Parkinson's disease and neuroplasticity. She did her postdoctoral training at Somatix Therapy Corp. and The Parkinson's Institute in Sunnyvale, California, where she further studied pre-clinical models and analyzed methods of cell transplantation and gene therapy.
In 1996, after a brief fellowship in the department of Pharmacology at the University of Michigan in Ann Arbor, Dr. Emborg moved to Chicago. There she joined the Research Center for Brain Repair, in the department of Neurological Sciences at Rush-Presbyterian-St. Luke's Medical Center where she became an Assistant Professor and led studies that produced seminal work in vivogene therapy.
Since September 2004 she has been Senior Scientist at the Wisconsin National Primate Research Center, University of Wisconsin at Madison, where she directs the Parkinson's disease unit. Her goal at Wisconsin is to help find a cure for Parkinson's disease. Her current studies include mechanisms of cell degeneration and activation of neuroprotective pathways, in vivo and ex vivo gene therapy for trophic factor delivery and transplantation of embryonic and neural stem cells.